Integrating Hypertension Phenotype and Genotype with Hybrid Non-negative Matrix Factorization
Yuan Luo, Chengsheng Mao, Yiben Yang, Fei Wang, Faraz S. Ahmad, Donna, Arnett, Marguerite R. Irvin, Sanjiv J. Shah

TL;DR
This paper introduces Hybrid Non-negative Matrix Factorization (HNMF), a novel method for integrating phenotypic and genotypic data to improve hypertension subtyping, with better interpretability and predictive performance.
Contribution
The paper presents HNMF, a new approach that combines phenotype and genotype data using different loss functions, enhancing patient stratification and understanding of hypertension.
Findings
HNMF converges quickly and accurately in simulations.
HNMF outperforms six other models in predicting cardiac outcomes.
HNMF reveals meaningful phenotype-genotype interactions.
Abstract
Hypertension is a heterogeneous syndrome in need of improved subtyping using phenotypic and genetic measurements so that patients in different subtypes share similar pathophysiologic mechanisms and respond more uniformly to targeted treatments. Existing machine learning approaches often face challenges in integrating phenotype and genotype information and presenting to clinicians an interpretable model. We aim to provide informed patient stratification by introducing Hybrid Non-negative Matrix Factorization (HNMF) on phenotype and genotype matrices. HNMF simultaneously approximates the phenotypic and genetic matrices using different appropriate loss functions, and generates patient subtypes, phenotypic groups and genetic groups. Unlike previous methods, HNMF approximates phenotypic matrix under Frobenius loss, and genetic matrix under Kullback-Leibler (KL) loss. We propose an…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGene expression and cancer classification · Genetic Associations and Epidemiology · Genomic variations and chromosomal abnormalities
